|  |
Tripos and Crown Partners Form Strategic Alliance
Tripos, Inc., and Crown Partners LLC announced the formation of a strategic relationship combining Crown Partners' enterprise-scale content management solution with Tripos' electronic notebook offering. The relationship strengthens the Tripos Electronic Notebook(TM) solution by including workflow, collaboration and content management technologies from Documentum, and provides the electronic notebook with comprehensive support for intellectual property issues involved in the research and development life cycle.
Through a combination of leading expertise in chemistry research, best practice consulting, and the development of innovative drug discovery informatics technologies, Tripos implements custom notebook solutions that best fit the scientific workflow and business goals of its customers. The core technologies used within the Tripos Electronic Notebook were developed in collaboration with a leading pharmaceutical company to document and share scientific information, and eliminate storage of laboratory data in disparate archives.
"Laboratory informatics technologies must seamlessly align with an organization's overall knowledge management strategy, especially enterprisewide systems like electronic notebooks," said Dr. Trevor Heritage, senior vice president and general manager of Discovery Informatics at Tripos. "Crown Partners' exclusive status as a Documentum Signature Partner provides Tripos' clients with a unique combination of strength in e-notebooks and content management technologies."
Crown Partners has expertise developing standardized processes and content management solutions that leverage the Documentum Enterprise Content Management platform with extensive experience in scalable processes and technologies.
"Crown Partners selects only best-of-breed technology partners to deliver its enterprise content management solutions," said Richard Hearn, senior managing partner of Crown Partners Consulting Group. "Tripos' chemistry and informatics experience provides a truly unique perspective for the drug discovery sector and is a good addition to our partner strategy." 04.06.2004, Tripos, Inc.
Subscribe to the newsletter | | |
| | | |
